JCR Pharmaceuticals
CompanyJapanFounded 1975
JCR Pharmaceuticals develops one asset, in human trials (JR-141 in Hunter syndrome). Mostly protein or enzyme acting on proteostasis and IDS; based in Japan, founded in 1975.
- 1
- Asset
- Furthest stage
- Human trials
- 0
- Trials
- 2
- Signals
Pipeline
1Recombinant iduronate-2-sulfatase enzyme replacement therapy engineered to penetrate the blood-brain barrier.
Human trials, Protein or enzyme, Proteostasis, IDS, Hunter syndrome
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Evidence behind the mechanisms1
- Signals2
- Similar companies6